Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1260097.RA-OKb_PSRCk6c0EcFrqHaM0qTS2RLaJ9VGjv1iHPfV4I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1260097.RA-OKb_PSRCk6c0EcFrqHaM0qTS2RLaJ9VGjv1iHPfV4I130_assertion type Assertion NP1260097.RA-OKb_PSRCk6c0EcFrqHaM0qTS2RLaJ9VGjv1iHPfV4I130_head.
- NP1260097.RA-OKb_PSRCk6c0EcFrqHaM0qTS2RLaJ9VGjv1iHPfV4I130_assertion description "[A total of 212 hepatitis B e antigen (HBeAg)-positive patients treated with a 48weeks of PEG-IFN monotherapy were enrolled initially and 127 patients were followed for 48weeks posttreatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260097.RA-OKb_PSRCk6c0EcFrqHaM0qTS2RLaJ9VGjv1iHPfV4I130_provenance.
- NP1260097.RA-OKb_PSRCk6c0EcFrqHaM0qTS2RLaJ9VGjv1iHPfV4I130_assertion evidence source_evidence_literature NP1260097.RA-OKb_PSRCk6c0EcFrqHaM0qTS2RLaJ9VGjv1iHPfV4I130_provenance.
- NP1260097.RA-OKb_PSRCk6c0EcFrqHaM0qTS2RLaJ9VGjv1iHPfV4I130_assertion SIO_000772 25640825 NP1260097.RA-OKb_PSRCk6c0EcFrqHaM0qTS2RLaJ9VGjv1iHPfV4I130_provenance.
- NP1260097.RA-OKb_PSRCk6c0EcFrqHaM0qTS2RLaJ9VGjv1iHPfV4I130_assertion wasDerivedFrom befree-2016 NP1260097.RA-OKb_PSRCk6c0EcFrqHaM0qTS2RLaJ9VGjv1iHPfV4I130_provenance.
- NP1260097.RA-OKb_PSRCk6c0EcFrqHaM0qTS2RLaJ9VGjv1iHPfV4I130_assertion wasGeneratedBy ECO_0000203 NP1260097.RA-OKb_PSRCk6c0EcFrqHaM0qTS2RLaJ9VGjv1iHPfV4I130_provenance.